Arbutus Biopharma Corp Financing Cash Flow
Arbutus Biopharma Corp (ABUS) reported Financing Cash Flow of $14.77 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-08-12
CAD
| Period end | Net Cash Provided by (Used in) Financing Activities 12 month | Net Cash Provided by (Used in) Financing Activities 12 month as first filed |
|---|---|---|
| 2012-12-31 | 4.54M CAD 20-F · filed 2013-03-27 | |
| 2011-12-31 | 4.56M CAD 20-F · filed 2013-03-27 | 10.66K CAD 20-F · filed 2012-03-27 |
| 2010-12-31 | 34.91K CAD 20-F · filed 2013-03-27 | |
| 2009-12-31 | 7.89K CAD 20-F · filed 2012-03-27 |
USD
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 3 month as first filed | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month | Net Cash Provided by (Used in) Financing Activities 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3.15M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $14.77M 10-Q · filed 2026-08-12 | $16.41M derived: sum of 3 quarters · filed 2026-08-12 | $17.25M derived: sum of 4 quarters · filed 2026-08-12 | ||
| 2026-03-31 | $11.62M 10-Q · filed 2026-05-13 | $13.26M derived: sum of 2 quarters · filed 2026-05-13 | $14.10M derived: sum of 3 quarters · filed 2026-05-13 | $14.56M derived: sum of 4 quarters · filed 2026-08-12 | ||
| 2025-12-31 | $1.64M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-23 | $2.48M derived: sum of 2 quarters · filed 2026-03-23 | $2.94M derived: sum of 3 quarters · filed 2026-08-12 | $5.72M 10-K · filed 2026-03-23 | ||
| 2025-09-30 | $844.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $1.30M derived: sum of 2 quarters · filed 2026-08-12 | $4.08M 10-Q · filed 2025-11-13 | $5.50M derived: sum of 4 quarters · filed 2026-08-12 | ||
| 2025-06-30 | $453.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $3.24M 10-Q · filed 2026-08-12 | $4.66M derived: sum of 3 quarters · filed 2026-08-12 | $6.43M derived: sum of 4 quarters · filed 2026-08-12 | ||
| 2025-03-31 | $2.78M 10-Q · filed 2026-05-13 | $4.21M derived: sum of 2 quarters · filed 2026-05-13 | $5.98M derived: sum of 3 quarters · filed 2026-05-13 | $30.35M derived: sum of 4 quarters · filed 2026-05-13 | ||
| 2024-12-31 | $1.42M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-23 | $3.20M derived: sum of 2 quarters · filed 2026-03-23 | $27.57M derived: sum of 3 quarters · filed 2026-03-23 | $52.00M 10-K · filed 2026-03-23 | ||
| 2024-09-30 | $1.77M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $26.14M derived: sum of 2 quarters · filed 2025-11-13 | $50.58M 10-Q · filed 2025-11-13 | $54.38M derived: sum of 4 quarters · filed 2025-11-13 | ||
| 2024-06-30 | $24.37M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $48.80M 10-Q · filed 2025-08-06 | $52.61M derived: sum of 3 quarters · filed 2025-08-06 | $54.29M derived: sum of 4 quarters · filed 2025-08-06 | ||
| 2024-03-31 | $24.43M 10-Q · filed 2025-05-14 | $28.24M derived: sum of 2 quarters · filed 2025-05-14 | $29.92M derived: sum of 3 quarters · filed 2025-05-14 | $34.66M derived: sum of 4 quarters · filed 2025-05-14 | ||
| 2023-12-31 | $3.81M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $5.49M derived: sum of 2 quarters · filed 2025-03-27 | $10.23M derived: sum of 3 quarters · filed 2025-03-27 | $30.65M 10-K · filed 2025-03-27 | ||
| 2023-09-30 | $1.68M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $6.42M derived: sum of 2 quarters · filed 2024-11-06 | $26.84M 10-Q · filed 2024-11-06 | $37.92M derived: sum of 4 quarters · filed 2024-11-06 | ||
| 2023-06-30 | $4.74M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $25.16M 10-Q · filed 2024-08-08 | $36.24M derived: sum of 3 quarters · filed 2024-08-08 | $45.38M derived: sum of 4 quarters · filed 2024-08-08 | ||
| 2023-03-31 | $20.42M 10-Q · filed 2024-05-02 | $31.50M derived: sum of 2 quarters · filed 2024-05-02 | $40.63M derived: sum of 3 quarters · filed 2024-05-02 | $40.75M derived: sum of 4 quarters · filed 2024-05-02 | ||
| 2022-12-31 | $11.08M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05 | $20.22M derived: sum of 2 quarters · filed 2024-03-05 | $20.33M derived: sum of 3 quarters · filed 2024-03-05 | $31.81M 10-K · filed 2024-03-05 | ||
| 2022-09-30 | $9.13M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $9.24M derived: sum of 2 quarters · filed 2023-11-07 | $20.73M 10-Q · filed 2023-11-07 | $79.85M derived: sum of 4 quarters · filed 2023-11-07 | ||
| 2022-06-30 | $113.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $11.60M 10-Q · filed 2023-08-03 | $70.72M derived: sum of 3 quarters · filed 2023-08-03 | $117.67M derived: sum of 4 quarters · filed 2023-08-03 | ||
| 2022-03-31 | $11.48M 10-Q · filed 2023-05-04 | $70.61M derived: sum of 2 quarters · filed 2023-05-04 | $117.56M derived: sum of 3 quarters · filed 2023-05-04 | $121.85M derived: sum of 4 quarters · filed 2023-05-04 | ||
| 2021-12-31 | $59.12M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | $106.07M derived: sum of 2 quarters · filed 2023-03-02 | $110.36M derived: sum of 3 quarters · filed 2023-03-02 | $137.24M 10-K · filed 2023-03-02 | ||
| 2021-09-30 | $46.95M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $51.24M derived: sum of 2 quarters · filed 2022-11-09 | $78.11M 10-Q · filed 2022-11-09 | $98.33M derived: sum of 4 quarters · filed 2022-11-09 | ||
| 2021-06-30 | $4.29M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $31.16M 10-Q · filed 2022-08-04 | $51.37M derived: sum of 3 quarters · filed 2022-08-04 | $100.47M derived: sum of 4 quarters · filed 2022-08-04 | ||
| 2021-03-31 | $26.87M 10-Q · filed 2022-05-05 | $47.08M derived: sum of 2 quarters · filed 2022-05-05 | $96.18M derived: sum of 3 quarters · filed 2022-05-05 | $101.14M derived: sum of 4 quarters · filed 2022-05-05 | ||
| 2020-12-31 | $20.21M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-03 | $69.31M derived: sum of 2 quarters · filed 2022-03-03 | $74.27M derived: sum of 3 quarters · filed 2022-03-03 | $86.75M 10-K · filed 2022-03-03 | ||
| 2020-09-30 | $49.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $54.05M derived: sum of 2 quarters · filed 2021-11-04 | $66.54M 10-Q · filed 2021-11-04 | $80.43M derived: sum of 4 quarters · filed 2021-11-04 | ||
| 2020-06-30 | $4.96M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $17.44M 10-Q · filed 2021-08-05 | $31.33M derived: sum of 3 quarters · filed 2021-08-05 | $49.88M derived: sum of 4 quarters · filed 2021-08-05 | ||
| 2020-03-31 | $12.48M 10-Q · filed 2021-05-05 | $26.37M derived: sum of 2 quarters · filed 2021-05-05 | $44.92M derived: sum of 3 quarters · filed 2021-05-05 | $47.40M derived: sum of 4 quarters · filed 2021-05-05 | ||
| 2019-12-31 | $13.89M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-04 | $32.44M derived: sum of 2 quarters · filed 2021-03-04 | $34.92M derived: sum of 3 quarters · filed 2021-03-04 | $37.46M 10-K · filed 2021-03-04 | ||
| 2019-09-30 | $18.55M 10-Q · filed 2019-11-06 | $21.03M derived: sum of 2 quarters · filed 2019-11-06 | $23.56M 10-Q · filed 2020-11-05 | $23.67M derived: sum of 4 quarters · filed 2020-05-11 | ||
| 2019-06-30 | $2.48M 10-Q · filed 2019-08-05 | $5.01M 10-Q · filed 2020-08-07 | $5.12M derived: sum of 3 quarters · filed 2020-05-11 | $5.56M derived: sum of 4 quarters · filed 2020-05-11 | ||
| 2019-03-31 | $2.54M 10-Q · filed 2020-05-11 | $2.65M derived: sum of 2 quarters · filed 2020-05-11 | $3.08M derived: sum of 3 quarters · filed 2020-05-11 | $3.81M derived: sum of 4 quarters · filed 2020-05-11 | ||
| 2018-12-31 | $109.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-05 | $544.00K derived: sum of 2 quarters · filed 2020-03-05 | $1.28M derived: sum of 3 quarters · filed 2020-03-05 | $55.65M 10-K · filed 2020-03-05 | ||
| 2018-09-30 | $435.00K 10-Q · filed 2019-11-06 | $1.17M derived: sum of 2 quarters · filed 2019-11-06 | $55.54M 10-Q · filed 2019-11-06 | $104.44M derived: sum of 4 quarters · filed 2019-11-06 | ||
| 2018-06-30 | $735.00K 10-Q · filed 2019-08-05 | $55.10M 10-Q · filed 2019-08-05 | $104.00M derived: sum of 3 quarters · filed 2019-08-05 | $104.07M derived: sum of 4 quarters · filed 2019-08-05 | ||
| 2018-03-31 | $54.37M 10-Q · filed 2019-05-06 | $103.27M derived: sum of 2 quarters · filed 2019-05-06 | $103.33M derived: sum of 3 quarters · filed 2019-05-06 | $103.33M derived: sum of 4 quarters · filed 2019-05-06 | ||
| 2017-12-31 | $48.90M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07 | $48.96M derived: sum of 2 quarters · filed 2019-03-07 | $48.97M derived: sum of 3 quarters · filed 2019-03-07 | $49.32M 10-K · filed 2019-03-07 | ||
| 2017-09-30 | $61.00K 10-Q · filed 2018-11-07 | $65.00K derived: sum of 2 quarters · filed 2018-11-07 | $419.00K 10-Q · filed 2018-11-07 | $12.42M derived: sum of 4 quarters · filed 2018-11-07 | ||
| 2017-06-30 | $4.00K 10-Q · filed 2018-08-03 | $358.00K 10-Q · filed 2018-08-03 | $12.36M derived: sum of 3 quarters · filed 2018-08-03 | $12.44M derived: sum of 4 quarters · filed 2018-08-03 | ||
| 2017-03-31 | $354.00K 10-Q · filed 2018-05-04 | $12.36M derived: sum of 2 quarters · filed 2018-05-04 | $12.43M derived: sum of 3 quarters · filed 2018-05-04 | $12.88M derived: sum of 4 quarters · filed 2018-05-04 | ||
| 2016-12-31 | $12.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16 | $12.08M derived: sum of 2 quarters · filed 2018-03-16 | $12.52M derived: sum of 3 quarters · filed 2018-03-16 | $12.64M 10-K · filed 2018-03-16 | ||
| 2016-09-30 | $76.00K 10-Q · filed 2017-11-02 | $522.00K derived: sum of 2 quarters · filed 2017-11-02 | $637.00K 10-Q · filed 2017-11-02 | $612.00K derived: sum of 4 quarters · filed 2018-03-16 | ||
| 2016-06-30 | $446.00K 10-Q · filed 2017-08-03 | $561.00K 10-Q · filed 2017-08-03 | $536.00K derived: sum of 3 quarters · filed 2018-03-16 | $652.00K derived: sum of 4 quarters · filed 2018-03-16 | ||
| 2016-03-31 | $115.00K 10-Q · filed 2017-05-04 | $90.00K derived: sum of 2 quarters · filed 2018-03-16 | $206.00K derived: sum of 3 quarters · filed 2018-03-16 | $1.17M derived: sum of 4 quarters · filed 2018-03-16 | ||
| 2015-12-31 | -$25.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16 | $91.00K derived: sum of 2 quarters · filed 2018-03-16 | $1.05M derived: sum of 3 quarters · filed 2018-03-16 | $143.87M 10-K · filed 2018-03-16 | ||
| 2015-09-30 | $116.00K 10-Q · filed 2016-11-03 | $1.08M derived: sum of 2 quarters · filed 2016-11-03 | $143.90M 10-Q · filed 2016-11-03 | $144.37M derived: sum of 4 quarters · filed 2017-03-22 | ||
| 2015-06-30 | $960.00K 10-Q · filed 2016-08-04 | $143.78M 10-Q · filed 2016-08-04 | $144.25M derived: sum of 3 quarters · filed 2017-03-22 | $144.93M derived: sum of 4 quarters · filed 2017-03-22 | ||
| 2015-03-31 | $142.82M 10-Q · filed 2016-05-04 | $143.29M derived: sum of 2 quarters · filed 2017-03-22 | $143.97M derived: sum of 3 quarters · filed 2017-03-22 | $144.21M derived: sum of 4 quarters · filed 2017-03-22 | ||
| 2014-12-31 | $469.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-22 | $1.15M derived: sum of 2 quarters · filed 2017-03-22 | $1.39M derived: sum of 3 quarters · filed 2017-03-22 | $60.68M 10-K · filed 2017-03-22 | ||
| 2014-09-30 | $684.00K 10-Q · filed 2015-11-05 | $918.00K derived: sum of 2 quarters · filed 2015-11-05 | $60.21M 10-Q · filed 2015-11-05 | $92.64M derived: sum of 4 quarters · filed 2016-03-09 | ||
| 2014-06-30 | $234.00K 10-Q · filed 2015-08-07 | $59.52M 10-Q · filed 2015-08-07 | $91.96M derived: sum of 3 quarters · filed 2016-03-09 | $92.03M derived: sum of 4 quarters · filed 2016-03-09 | ||
| 2014-03-31 | $59.29M 10-Q · filed 2015-05-06 | $91.72M derived: sum of 2 quarters · filed 2016-03-09 | $91.80M derived: sum of 3 quarters · filed 2016-03-09 | $91.88M derived: sum of 4 quarters · filed 2016-03-09 | ||
| 2013-12-31 | $32.43M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-09 | $32.51M derived: sum of 2 quarters · filed 2016-03-09 | $32.59M derived: sum of 3 quarters · filed 2016-03-09 | $32.72M 10-K · filed 2016-03-09 | $32.72M 6-K · filed 2014-03-06 | |
| 2013-09-30 | $76.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07 | $152.00K derived: sum of 2 quarters · filed 2014-11-07 | $282.00K 10-Q · filed 2014-11-07 | |||
| 2013-06-30 | $76.00K 10-Q · filed 2014-11-07 | $68.00K 10-Q · filed 2014-08-14 | $206.00K 10-Q · filed 2014-08-14 | |||
| 2013-03-31 | $138.00K 10-Q · filed 2014-05-14 | |||||
| 2012-12-31 | $4.55M 10-K · filed 2015-03-13 | $4.55M 6-K · filed 2014-03-06 | ||||
| 2011-12-31 | $4.61M 10-K · filed 2014-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 |